LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
126 hedge funds and large institutions have $142M invested in Lumos Pharma, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $196M → $142M (-$53.8M)
Holders
126
Holding in Top 10
–
Calls
$14.9M
Puts
$4.08M
Top Buyers
| 1 | +$3.52M | |
| 2 | +$3.1M | |
| 3 | +$1.51M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.49M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.31M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$12.7M | |
| 3 | -$6.45M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$3.65M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$3.63M |